Boston, MA -- (SBWIRE) -- 12/05/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Cemex SAB de CV (ADR) (NYSE:CX), Novavax, Inc. (NASDAQ:NVAX), Glu Mobile Inc. (NASDAQ:GLUU), OncoSec Medical Inc (OTCMKTS:ONCS).
Cemex SAB de CV (ADR) (NYSE:CX), opened its shares at the price of $10.80 for the day. Its closing price was $11.15 after gaining2.58% for the day. The company traded with the total volume of 17.58 million shares, while its average trading volume remained 12.81 million shares. The beta of CX stands at2.48.
Will CX Continue To Move Higher? Find Out Here
CEMEX, S.A.B. de C.V., through its subsidiaries, engages in the production and sale of cement, ready-mix concrete, aggregates, and other construction materials in Mexico, the United States, Northern Europe, the Mediterranean, South America, the Caribbean, and Asia.
Novavax, Inc. (NASDAQ:NVAX), percentage change surged0.75% to close at $4.01 with the total traded volume of 4.31 million shares, and average volume of 3.62 million. The 52 week range of the stock remained $1.68 - $4.08, while its day lowest price was $3.81and it hit its day highest price at $4.08.
Will NVAX Continue To Move Higher? Find Out Here
Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases.
Glu Mobile Inc. (NASDAQ:GLUU), started its trading session with the price of $3.44 and closed at $3.57 by scoring 3.78%. GLUU’s stocks traded with total volume of 1.66 million shares, while the average trading volume remained 3.92 million shares. The beta of GLUU stands at 1.70. Day range of the stock was $3.41 -$3.60.
Will GLUU Continue To Move Higher? Find Out Here
Glu Mobile Inc. develops and publishes a portfolio of action/adventure and casual games for the users of smartphones and tablet devices.
OncoSec Medical Inc (OTCMKTS:ONCS) ended its day with the loss of -6.25% and closed at the price of $0.300 after opening at $0.32. Stock traded during its last trading session with the total volume of 1.89 million shares, as compared to its average volume of 1.22 million shares.
Will ONCS Get Buyers Even After The Recent Rally? Find Out Here
OncoSec Medical Incorporated, a drug-medical device and therapeutic company, designs, develops, and commercializes medical approaches for the treatment of solid tumors in the United States.
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)